Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Cash from Restructuring (2016 - 2018)

Historic Cash from Restructuring for Macrogenics (MGNX) over the last 7 years, with Q1 2018 value amounting to -$298000.0.

  • Macrogenics' Cash from Restructuring rose 2137.2% to -$298000.0 in Q1 2018 from the same period last year, while for Mar 2019 it was -$298000.0, marking a year-over-year increase of 8029.1%. This contributed to the annual value of -$1.6 million for FY2017, which is 4355.07% up from last year.
  • Macrogenics' Cash from Restructuring amounted to -$298000.0 in Q1 2018, which was up 2137.2% from -$417000.0 recorded in Q4 2017.
  • Macrogenics' 5-year Cash from Restructuring high stood at -$298000.0 for Q1 2018, and its period low was -$2.0 million during Q2 2015.
  • Over the past 5 years, Macrogenics' median Cash from Restructuring value was -$392000.0 (recorded in 2017), while the average stood at -$555588.2.
  • As far as peak fluctuations go, Macrogenics' Cash from Restructuring tumbled by 45971.83% in 2015, and later surged by 7618.47% in 2017.
  • Macrogenics' Cash from Restructuring (Quarter) stood at -$372000.0 in 2014, then decreased by 23.66% to -$460000.0 in 2015, then increased by 24.13% to -$349000.0 in 2016, then decreased by 19.48% to -$417000.0 in 2017, then grew by 28.54% to -$298000.0 in 2018.
  • Its Cash from Restructuring stands at -$298000.0 for Q1 2018, versus -$417000.0 for Q4 2017 and -$405000.0 for Q3 2017.